HC Wainwright & Co. Maintains Buy on Rockwell Medical, Raises Price Target to $9
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Raghuram Selvaraju maintains a Buy rating on Rockwell Medical (NASDAQ:RMTI) and raises the price target from $7 to $9.
May 30, 2023 | 10:11 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. maintains a Buy rating on Rockwell Medical and raises the price target from $7 to $9.
The Buy rating and increased price target by HC Wainwright & Co. analyst Raghuram Selvaraju indicates a positive outlook for Rockwell Medical's stock. This news is likely to have a positive impact on the stock price in the short term as it reflects the analyst's confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100